BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28095352)

  • 1. The relationship of REL proto-oncogene to pathobiology and chemoresistance in follicular and transformed follicular lymphoma.
    Hu X; Baytak E; Li J; Akman B; Okay K; Hu G; Scuto A; Zhang W; Küçük C
    Leuk Res; 2017 Mar; 54():30-38. PubMed ID: 28095352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
    Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
    Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic analysis of the frequently amplified 2p15-p16.1 locus reveals PAPOLG as a potential proto-oncogene in follicular and transformed follicular lymphoma.
    Kurşun D; Küçük C
    Turk J Biol; 2019; 43():124-132. PubMed ID: 31410080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma.
    Bouska A; Zhang W; Gong Q; Iqbal J; Scuto A; Vose J; Ludvigsen M; Fu K; Weisenburger DD; Greiner TC; Gascoyne RD; Rosenwald A; Ott G; Campo E; Rimsza LM; Delabie J; Jaffe ES; Braziel RM; Connors JM; Wu CI; Staudt LM; D'Amore F; McKeithan TW; Chan WC
    Leukemia; 2017 Jan; 31(1):83-91. PubMed ID: 27389057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Importance of MicroRNA Deregulation in the Molecular Pathogenesis and Histological Transformation of Follicular Lymphoma].
    Musilová K; Deván J; Zlámalíková L; Křen L; Móciková H; Procházka V; Mayer J; Trněný M; Janíková A; Mráz M
    Klin Onkol; 2017; 30(Supplementum1):163-165. PubMed ID: 28471196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.
    Starczynowski DT; Trautmann H; Pott C; Harder L; Arnold N; Africa JA; Leeman JR; Siebert R; Gilmore TD
    Oncogene; 2007 Apr; 26(19):2685-94. PubMed ID: 17072339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying the role of aberrant somatic hypermutation in transformation of follicular lymphoma.
    Halldórsdóttir AM; Frühwirth M; Deutsch A; Aigelsreiter A; Beham-Schmid C; Agnarsson BA; Neumeister P; Richard Burack W
    Leuk Res; 2008 Jul; 32(7):1015-21. PubMed ID: 18180034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell of origin of transformed follicular lymphoma.
    Kridel R; Mottok A; Farinha P; Ben-Neriah S; Ennishi D; Zheng Y; Chavez EA; Shulha HP; Tan K; Chan FC; Boyle M; Meissner B; Telenius A; Sehn LH; Marra MA; Shah SP; Steidl C; Connors JM; Scott DW; Gascoyne RD
    Blood; 2015 Oct; 126(18):2118-27. PubMed ID: 26307535
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Musilova K; Devan J; Cerna K; Seda V; Pavlasova G; Sharma S; Oppelt J; Pytlik R; Prochazka V; Prouzova Z; Trbusek M; Zlamalikova L; Liskova K; Kruzova L; Jarosova M; Mareckova A; Kornauth C; Simonitsch-Klupp I; Schiefer AI; Merkel O; Mocikova H; Burda P; Machova Polakova K; Kren L; Mayer J; Zent CS; Trneny M; Evans AG; Janikova A; Mraz M
    Blood; 2018 Nov; 132(22):2389-2400. PubMed ID: 30213873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell growth in aggregates determines gene expression, proliferation, survival, chemoresistance, and sensitivity to immune effectors in follicular lymphoma.
    Gravelle P; Jean C; Familiades J; Decaup E; Blanc A; Bezombes-Cagnac C; Laurent C; Savina A; Fournié JJ; Laurent G
    Am J Pathol; 2014 Jan; 184(1):282-95. PubMed ID: 24231431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma.
    Bouska A; McKeithan TW; Deffenbacher KE; Lachel C; Wright GW; Iqbal J; Smith LM; Zhang W; Kucuk C; Rinaldi A; Bertoni F; Fitzgibbon J; Fu K; Weisenburger DD; Greiner TC; Dave BJ; Gascoyne RD; Rosenwald A; Ott G; Campo E; Rimsza LM; Delabie J; Jaffe ES; Braziel RM; Connors JM; Staudt LM; Chan WC
    Blood; 2014 Mar; 123(11):1681-90. PubMed ID: 24037725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma.
    Goy A; Stewart J; Barkoh BA; Remache YK; Katz R; Sneige N; Gilles F
    Cancer; 2006 Feb; 108(1):10-20. PubMed ID: 16329118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
    Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
    J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice.
    Thornburg NJ; Kulwichit W; Edwards RH; Shair KH; Bendt KM; Raab-Traub N
    Oncogene; 2006 Jan; 25(2):288-97. PubMed ID: 16247482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma.
    Goff LK; Neat MJ; Crawley CR; Jones L; Jones E; Lister TA; Gupta RK
    Br J Haematol; 2000 Nov; 111(2):618-25. PubMed ID: 11122110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of t(14;18) in Hodgkin's lymphoma associated with follicular lymphoma.
    Yoshida M; Ichikawa A; Miyoshi H; Takeuchi M; Kimura Y; Nino D; Ohshima K
    Pathol Int; 2012 Aug; 62(8):518-24. PubMed ID: 22827759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and comprehensive analysis of a new human transformed follicular lymphoma B cell line, Tat-1.
    Denyssevych T; Lestou VS; Knesevich S; Robichaud M; Salski C; Tan R; Gascoyne RD; Horsman DE; Mayer LD
    Leukemia; 2002 Feb; 16(2):276-83. PubMed ID: 11840295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs.
    Devan J; Janikova A; Mraz M
    Semin Oncol; 2018 Oct; 45(5-6):291-302. PubMed ID: 30360879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Recurrent Mutations in the microRNA-Binding Sites of B-Cell Lymphoma-Associated Genes in Follicular Lymphoma.
    Larrea E; Fernandez-Mercado M; Guerra-Assunção JA; Wang J; Goicoechea I; Gaafar A; Ceberio I; Lobo C; Okosun J; Enright AJ; Fitzgibbon J; Lawrie CH
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Oncogenic Transcription Factor REL by the Natural Product Derivative Calafianin Monomer 101 Induces Proliferation Arrest and Apoptosis in Human B-Lymphoma Cell Lines.
    Yeo AT; Chennamadhavuni S; Whitty A; Porco JA; Gilmore TD
    Molecules; 2015 Apr; 20(5):7474-94. PubMed ID: 25915462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.